Gamma-ray Irradiation of Rodent Diets Alters the Urinary Metabolome in Rats with Chemically Induced Mammary Cancer

por Prasain, Jeevan K., Wilson, Landon S., Grubbs, Clinton, Barnes, Stephen
Publicado 2022

Pharmacometabolomic Pathway Response of Effective Anticancer Agents on Different Diets in Rats with Induced Mammary Tumors

por Cao, Zhijun, Miller, Mark Steven, Lubet, Ronald A., Grubbs, Clinton J., Beger, Richard D.
Publicado 2019

Diffusion Weighted Imaging Evaluated the Early Therapy Effect of Tamoxifen in an MNU-Induced Mammary Cancer Rat Model

por Zhai, Guihua, Grubbs, Clinton J., Stockard, Cecil R., Umphrey, Heidi R., Beasley, T. Mark, Kim, Hyunki
Publicado 2013

Daily or weekly dosing with EGFR inhibitors, gefitinib and lapatinib, and AKT inhibitor MK2206 in mammary cancer models

por Lubet, Ronald A., Steele, Vernon E., Juliana, M.M., Bode, Ann, Moeinpour, Fariba, Grubbs, Clinton J.
Publicado 2018

Daily or weekly dosing with EGFR inhibitors, gefitinib and lapatinib, and AKT inhibitor MK2206 in mammary cancer models

por Lubet, Ronald A., Steele, Vernon E., Juliana, M.M., Bode, Ann, Moeinpour, Fariba, Grubbs, Clinton J.
Publicado 2019

Effects of High-Fructose Diet vs. Teklad Diet in the MNU-Induced Rat Mammary Cancer Model: Altered Tumorigenesis, Metabolomics and Tumor RNA Expression

por Kumar, Amit, Lubet, Ronald A., Fox, Jennifer T., Nelson, William G., Seifried, Harold, Grubbs, Clinton J., Miller, Mark Steven
Publicado 2021

Lack of chemopreventive efficacy of metformin in rodent models of urinary bladder, head and neck, and colon/intestine cancer

por Thompson, Matthew D., Lubet, Ronald A., Mccormick, David L., Clapper, Margie L., Bode, Ann M., Juliana, M. Margaret, Moeinpour, Fariba, Grubbs, Clinton J.
Publicado 2017

Methyl Substitution of a Rexinoid Agonist Improves Potency and Reveals Site of Lipid Toxicity

por Atigadda, Venkatram R., Xia, Gang, Desphande, Anil, Boerma, LeeAnn J., Lobo-Ruppert, Susan, Grubbs, Clinton J., Smith, Craig D., Brouillette, Wayne J., Muccio, Donald D.
Publicado 2014

Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in Rats

por Tinsley, Heather N., Mathew, Bini, Chen, Xi, Maxuitenko, Yulia Y., Li, Nan, Lowe, Whitney M., Whitt, Jason D., Zhang, Wei, Gary, Bernard D., Keeton, Adam B., Grizzle, William E., Grubbs, Clinton J., Reynolds, Robert C., Piazza, Gary A.
Publicado 2023